A Calgary doctor predicts generic versions of Ozempic and Wegovy could reduce costs by up to a third. Learn about the patent expiry and five companies seeking approval to manufacture cheaper alternatives in Canada.
Health Canada reviews nine generic semaglutide submissions. Cheaper versions of Ozempic and Wegovy could soon improve access for diabetes and weight loss patients in British Columbia.
Semaglutide, sold as Ozempic, is now off-patent in Canada. This move could slash costs by up to 75%, dramatically increasing access to the popular diabetes and weight-loss drug for Canadians.
Generic versions of weight-loss drug Ozempic could slash costs from $400 to under $100 per month in Quebec following a key patent expiration, potentially increasing access for hundreds of thousands.
Canadian companies can begin producing generic versions of Ozempic starting next week, but experts warn patients should not expect immediate access due to manufacturing and distribution timelines.
U.S. telehealth giant Hims & Hers acquires Canadian platform Livewell, positioning itself to launch generic semaglutide (Ozempic) in Canada as Novo Nordisk's patent lapses. The move targets a market where two-thirds of adults face weight-related health ch
Discover the truth about 'Ozempic penis' - the viral claim about GLP-1 medications. Urologists explain why it's an optical illusion and reveal real sexual side effects.